Perry Evans

Also affiliated with Spark Therapeutics (United States)

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival”.

Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad183

N/A

0DataRank · unranked

27 citations

Zalman Vaksman, Laura E. Egolf, Rebecca S. Kaufman, Perry Evans, Karina L. Conkrite +23 more

BARD1germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad182

N/A

0DataRank · unranked

25 citations

Laura E. Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff +8 more

Germline pathogenic variants in 786 neuroblastoma patients

medRxiv(2023)10.1101/2023.01.23.23284864

N/A

0DataRank · unranked

6 citations

Zalman Vaksman, Laura E. Egolf, Rebecca S. Kaufman, Perry Evans, Karina L. Conkrite +23 more

BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.31.525066

N/A

0DataRank · unranked

3 citations

Laura E. Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff +8 more